Skip to main
CERT

Certara (CERT) Stock Forecast & Price Target

Certara (CERT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Certara is expected to drive strong growth and profitability in the coming quarters due to a combination of factors such as increased production levels (+35% YoY in 2Q26), improved silver recovery rates, and a favorable pricing environment. Additionally, the company has a strong presence in key revenue-generating markets and a diverse portfolio of biosimulation software and technology that helps reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. With its recent court victory, upcoming BFS and PEA for key assets, and a sharp focus on its differentiated MIDD/biosimulation assets, CERT is well-positioned for long-term growth and profitability.

Bears say

Certara is facing several fundamental headwinds, including slower than expected revenue growth, a shift towards project-based business in its QSP segment, struggles in the Asian market, and potential passive selling pressure from small-cap market indexes. These issues, along with limited financial impact from partnerships and a longer-term outlook for new CEO initiatives, suggest that the company may face challenges in increasing profitability and attracting investors. Additionally, the company's ongoing investment in AI and regulatory initiatives may take time to yield results, posing a risk to its near-term financial performance.

Certara (CERT) has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Certara and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Certara (CERT) Forecast

Analysts have given Certara (CERT) a Hold based on their latest research and market trends.

According to 8 analysts, Certara (CERT) has a Hold consensus rating as of Aug 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Certara (CERT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.